CIM
ABMD

CIM Investment Management’s Abiomed Inc ABMD Stock Holding History

CIM Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,206
Closed -$718K – 250
2019
Q4 		$718K Buy
4,206
+2,030
+93% +$376K 0.28% 79
2019
Q3 		$387K Sell
2,176
-230
-10% -$49.7K 0.14% 174
2019
Q2 		$627K Buy
+2,406
New +$638K 0.23% 91
2016
Q2 		– Sell
-4,339
Closed -$411K – 313
2016
Q1 		$411K Buy
4,339
+1,882
+77% +$159K 0.18% 154
2015
Q4 		$222K Buy
+2,457
New +$209K 0.1% 223

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIM Investment Management's ABMD Position: Q1 2020 in Review

CIM Investment Management sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 4,206 shares — an estimated $718K sold.

CIM Investment Management first reported a position in ABMD in Q4 2015 and held it in 5 quarters. The position peaked at $718K in Q4 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • CIM Investment Management reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • CIM Investment Management sold 4,206 Abiomed Inc shares in Q1 2020, an estimated $718K.
  • CIM Investment Management first reported a position in Abiomed Inc in Q4 2015 and held it in 5 quarters.
  • CIM Investment Management's Abiomed Inc position peaked at $718K in Q4 2019.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on CIM Investment Management's 13F filing for Q1 2020, filed 22 May 2020.